Title: ______________________________________________________________________
Official Title: ______________________________________________________________________
Number of Sections: 3
Source: versions - Amendment H1
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
Hall of the House of Representatives
95th General Assembly - Regular Session, 2025
Amendment Form
Subtitle of House Bill 1301
TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY ACT.
______________________________________________________________________
Amendment No. 1 to House Bill 1301
Amend House Bill 1301 as originally introduced:
Page 1, delete line 19, and substitute the following:
"SECTION 1. Arkansas Code § 23-99-1103, concerning the definitions
used in the Prior Authorization Transparency Act, is amended to add an
additional subdivision to read as follows:
(23) "Gold card program" means the process described in §§ 23-
99-1120 — 23-99-1126 under which a healthcare provider may qualify for an
exemption from a healthcare insurer's or pharmacy benefits manager's prior
authorization requirements.

Section 2:
SECTION 2. Arkansas Code § 23-99-1120 is amended to read as follows:"
AND
Page 9, delete lines 31 through 33, and substitute the following:
"(e)(1) Prescription drugs, medicines, biological products,
pharmaceuticals, or pharmaceutical services are exempt as a healthcare
service for purposes of §§ 23-99-1120 — 23-99-1126 until December 31, 2024
subject to the gold card program unless exempted from the gold card program
under § 23-99-1128(b)."
AND
Page 10, delete lines 12 through 36, and substitute the following:
*.ANS207*
ANS207 - 02-04-2025 09:31:16 Page 1 of 4
"SECTION 8. Arkansas Code § 23-99-1128 is amended to read as follows:
23-99-1128. Prescription drugs, medicines, biological products,
pharmaceuticals, or pharmaceutical services.
(a)(1) Beginning on January 1, 2024, a healthcare insurer or pharmacy
benefits manager shall submit a written request to the Arkansas State Board
of Pharmacy for any prescription drug, medicine, biological product,
pharmaceutical, or pharmaceutical service to be reviewed for a continuation
of prior authorization by a specified health benefit plan whether or not a
healthcare provider has met the criteria for an exemption from prior
authorization under §§ 23-99-1120 — 23-99-1126.
(2) The request under subdivision (a)(1) of this section shall
state the reason the request is being made for each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service for
the specified health benefit plan If a prescription drug, medicine,
biological product, pharmaceutical, or pharmaceutical service is not exempt
from the gold card program under subsection (b) of this section, then a
healthcare provider shall be reviewed by a healthcare insurer or pharmacy
benefits manager under the gold card program for the prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service.
(b)(1) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, may establish criteria and procedures to review
whether a request made under subdivision (a)(1) of this section should be
granted for the requesting party and specified health benefit plan For a
prescription drug, medicine, biological product, pharmaceutical, or
pharmaceutical service to be exempt from the gold card program, a healthcare
insurer or pharmacy benefits manager may submit a written request to the
Arkansas State Board of Pharmacy for approval.
(2) A request under subdivision (b)(1) of this section shall
state the reason the request is being made for each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service for
which exemption from the gold card program is requested.
(3) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, shall establish criteria and procedures to review
whether a request for exemption from the gold card program made under
subdivision (b)(1) of this section should be granted.
(4) Under the criteria established and procedures described
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 2 of 4
under subdivision (b)(3) of this section, the Arkansas State Board of
Pharmacy and the Arkansas State Medical Board, jointly, shall determine
whether to approve a request to exempt a prescription drug, medicine,
biological product, pharmaceutical, or pharmaceutical service from the gold
card program.
(5) The Arkansas State Board of Pharmacy shall promptly notify
the entity that made the request of the joint decision made by the Arkansas
State Board of Pharmacy and the Arkansas State Medical Board.
(6) The decision of the Arkansas State Board of Pharmacy and the
Arkansas State Medical Board, jointly, regarding each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service shall
apply to all healthcare insurers or pharmacy benefits managers.
(7) The Arkansas State Board of Pharmacy shall post on the
Arkansas State Board of Pharmacy's website a list of prescription drugs,
medicines, biological products, pharmaceuticals, or pharmaceutical services
that are exempt from the gold card program.
(8) An approval for exemption from the gold card program is
valid for two (2) years from the date of the notice provided under
subdivision (b)(5) of this section.
(c)(1) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, may determine whether or not a prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service may
be subject to prior authorization by a health benefit plan under the criteria
and procedures under subsection (b) of this section.
(2) The Arkansas State Board of Pharmacy shall promptly notify
the entity that made the request of the joint decision made by the Arkansas
State Board of Pharmacy and the Arkansas State Medical Board.
(d) The Arkansas State Board of Pharmacy shall make available to any
person who requests it, a list for any health benefit plan of prescription
drugs, medicines, biological products, pharmaceuticals, or pharmaceutical
services that require a prior authorization under this section.

Section 3:
SECTION 9. Arkansas Code § 23-99-1129 is repealed.
23-99-1129. Appeals process for disallowance of prior authorization.
(a) If the Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, disallow a prior authorization of a prescription
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 3 of 4
drug, medicine, biological product, pharmaceutical, or pharmaceutical service
requested under § 23-99-1128, a healthcare insurer, pharmacy benefits
manager, or other interested party may file an appeal to the State Insurance
Department within ninety (90) days of the disallowance of the prior
authorization.
(b) No later than the thirtieth day after the date a healthcare
insurer, pharmacy benefits manager, or other interested party files an appeal
under subsection (a) of this section, the Insurance Commissioner shall
appoint an independent review organization to review the appeal.
(c) A healthcare insurer, pharmacy benefits manager, or other
interested party that files an appeal under subsection (a) of this section
shall pay for the independent review organization appointed under subsection
(b) of this section to review the appeal.
(d) A healthcare insurer, pharmacy benefits manager, or other
interested party is bound by the independent review organization's
determination of the appeal under this section."
AND
Page 11, delete lines 1 through 7
AND
Appropriately renumber the sections of the bill
The Amendment was read ________________________________________________________________________________
By: Representative L. Johnson
ANS207/ANS - 02-04-2025 09:31:16 _________________________
ANS207 Chief Clerk
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 4 of 4
[DELETED:  PA  " (S"]
[DELETED:  A P"2( (( ( ( (]
[DELETED:  A P ( ( ( (( ((S2(]
[DELETED:  A P((( _ C]


================================================================================

Raw Text:
Hall of the House of Representatives
95th General Assembly - Regular Session, 2025
Amendment Form
______________________________________________________________________
Subtitle of House Bill 1301
TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY ACT.
______________________________________________________________________
Amendment No. 1 to House Bill 1301
Amend House Bill 1301 as originally introduced:
Page 1, delete line 19, and substitute the following:
"SECTION 1. Arkansas Code § 23-99-1103, concerning the definitions
used in the Prior Authorization Transparency Act, is amended to add an
additional subdivision to read as follows:
(23) "Gold card program" means the process described in §§ 23-
99-1120 — 23-99-1126 under which a healthcare provider may qualify for an
exemption from a healthcare insurer's or pharmacy benefits manager's prior
authorization requirements.
SECTION 2. Arkansas Code § 23-99-1120 is amended to read as follows:"
AND
Page 9, delete lines 31 through 33, and substitute the following:
"(e)(1) Prescription drugs, medicines, biological products,
pharmaceuticals, or pharmaceutical services are exempt as a healthcare
service for purposes of §§ 23-99-1120 — 23-99-1126 until December 31, 2024
subject to the gold card program unless exempted from the gold card program
under § 23-99-1128(b)."
AND
Page 10, delete lines 12 through 36, and substitute the following:
*.ANS207*
ANS207 - 02-04-2025 09:31:16 Page 1 of 4

"SECTION 8. Arkansas Code § 23-99-1128 is amended to read as follows:
23-99-1128. Prescription drugs, medicines, biological products,
pharmaceuticals, or pharmaceutical services.
(a)(1) Beginning on January 1, 2024, a healthcare insurer or pharmacy
benefits manager shall submit a written request to the Arkansas State Board
of Pharmacy for any prescription drug, medicine, biological product,
pharmaceutical, or pharmaceutical service to be reviewed for a continuation
of prior authorization by a specified health benefit plan whether or not a
healthcare provider has met the criteria for an exemption from prior
authorization under §§ 23-99-1120 — 23-99-1126.
(2) The request under subdivision (a)(1) of this section shall
state the reason the request is being made for each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service for
the specified health benefit plan If a prescription drug, medicine,
biological product, pharmaceutical, or pharmaceutical service is not exempt
from the gold card program under subsection (b) of this section, then a
healthcare provider shall be reviewed by a healthcare insurer or pharmacy
benefits manager under the gold card program for the prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service.
(b)(1) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, may establish criteria and procedures to review
whether a request made under subdivision (a)(1) of this section should be
granted for the requesting party and specified health benefit plan For a
prescription drug, medicine, biological product, pharmaceutical, or
pharmaceutical service to be exempt from the gold card program, a healthcare
insurer or pharmacy benefits manager may submit a written request to the
Arkansas State Board of Pharmacy for approval.
(2) A request under subdivision (b)(1) of this section shall
state the reason the request is being made for each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service for
which exemption from the gold card program is requested.
(3) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, shall establish criteria and procedures to review
whether a request for exemption from the gold card program made under
subdivision (b)(1) of this section should be granted.
(4) Under the criteria established and procedures described
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 2 of 4

under subdivision (b)(3) of this section, the Arkansas State Board of
Pharmacy and the Arkansas State Medical Board, jointly, shall determine
whether to approve a request to exempt a prescription drug, medicine,
biological product, pharmaceutical, or pharmaceutical service from the gold
card program.
(5) The Arkansas State Board of Pharmacy shall promptly notify
the entity that made the request of the joint decision made by the Arkansas
State Board of Pharmacy and the Arkansas State Medical Board.
(6) The decision of the Arkansas State Board of Pharmacy and the
Arkansas State Medical Board, jointly, regarding each prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service shall
apply to all healthcare insurers or pharmacy benefits managers.
(7) The Arkansas State Board of Pharmacy shall post on the
Arkansas State Board of Pharmacy's website a list of prescription drugs,
medicines, biological products, pharmaceuticals, or pharmaceutical services
that are exempt from the gold card program.
(8) An approval for exemption from the gold card program is
valid for two (2) years from the date of the notice provided under
subdivision (b)(5) of this section.
(c)(1) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, may determine whether or not a prescription drug,
medicine, biological product, pharmaceutical, or pharmaceutical service may
be subject to prior authorization by a health benefit plan under the criteria
and procedures under subsection (b) of this section.
(2) The Arkansas State Board of Pharmacy shall promptly notify
the entity that made the request of the joint decision made by the Arkansas
State Board of Pharmacy and the Arkansas State Medical Board.
(d) The Arkansas State Board of Pharmacy shall make available to any
person who requests it, a list for any health benefit plan of prescription
drugs, medicines, biological products, pharmaceuticals, or pharmaceutical
services that require a prior authorization under this section.
SECTION 9. Arkansas Code § 23-99-1129 is repealed.
23-99-1129. Appeals process for disallowance of prior authorization.
(a) If the Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, disallow a prior authorization of a prescription
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 3 of 4

drug, medicine, biological product, pharmaceutical, or pharmaceutical service
requested under § 23-99-1128, a healthcare insurer, pharmacy benefits
manager, or other interested party may file an appeal to the State Insurance
Department within ninety (90) days of the disallowance of the prior
authorization.
(b) No later than the thirtieth day after the date a healthcare
insurer, pharmacy benefits manager, or other interested party files an appeal
under subsection (a) of this section, the Insurance Commissioner shall
appoint an independent review organization to review the appeal.
(c) A healthcare insurer, pharmacy benefits manager, or other
interested party that files an appeal under subsection (a) of this section
shall pay for the independent review organization appointed under subsection
(b) of this section to review the appeal.
(d) A healthcare insurer, pharmacy benefits manager, or other
interested party is bound by the independent review organization's
determination of the appeal under this section."
AND
Page 11, delete lines 1 through 7
AND
Appropriately renumber the sections of the bill
The Amendment was read ________________________________________________________________________________
By: Representative L. Johnson
ANS207/ANS - 02-04-2025 09:31:16 _________________________
ANS207 Chief Clerk
ANS207 - 02-04-2025 09:31:16 Amendment No. 1 to House Bill 1301 Page 4 of 4

[DELETED:  PA  " (S"]
[DELETED:  A P"2( (( ( ( (]
[DELETED:  A P ( ( ( (( ((S2(]
[DELETED:  A P((( _ C]